Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This open-label, randomized, Phase II research study will look to see whether an
investigational treatment combining bromfenac ophthalmic drops with ranibizumab intravitreal
injection is safe and effective for treating wet AMD as compared to ranibizumab alone.